Cost of revenue · 2013–2025

Novocure cost of revenue

$167M+21.6% · FY2025

Novocure (NVCR) reported $167M in cost of revenue for fiscal 2025, +21.6% year on year.

$7.0M2013$10.0M2014$20.6M2015$39.9M2016$55.6M2017$80.0M2018$88.6M2019$107M2020$115M2021$115M2022$128M2023$137M2024$167M2025
Novocure — Cost of revenue, 2013–2025
Fiscal yearCost of revenueChangeFiling
FY20252025-12-31$167M+21.6%Open →
FY20242024-12-31$137M+6.9%Open →
FY20232023-12-31$128M+11.7%Open →
FY20222022-12-31$115M−0.0%Open →
FY20212021-12-31$115M+7.9%Open →
FY20202020-12-31$107M+20.2%Open →
FY20192019-12-31$88.6M+10.7%Open →
FY20182018-12-31$80.0M+43.9%Open →
FY20172017-12-31$55.6M+39.5%Open →
FY20162016-12-31$39.9M+93.4%Open →
FY20152015-12-31$20.6M+105.4%Open →
FY20142014-12-31$10.0M+43.1%Open →
FY20132013-12-31$7.0M—Open →

Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +30.2%

Cost of revenue at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Novocure cost of revenue |url=https://companiesranked.com/en/company/novocure/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Novocure cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/novocure/cost-of-revenue

BibTeX

@misc{companiesranked-en-company-novocure-cost-of-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Novocure cost of revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/novocure/cost-of-revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001645113-26-000062 · July 23, 2026

{{cite web |title=Novocure cost of revenue — 10-Q (0001645113-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1645113/000164511326000062/nvcr-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-23}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Novocure overview